Achieve Reports Financial Results for Fourth Quarter and Year-End 2019 and Provides Update on Cytisinicline Development Program

Go back to Achieve Reports Financial Results for Fourth Quarter and Year-End 2019 and Provides Update on Cytisinicline Development Program
(NASDAQ: ACHV) Delayed: 4.85 -0.51 (9.51%)
Previous Close $5.36    52 Week High
Open $5.39    52 Week Low
Day High $5.50    P/E N/A 
Day Low $4.82    EPS
Volume 6,945,503